How Digital Twin Technology is Disrupting Healthcare

Digital twins sound like science fiction, but they are very much real. And they’re making headway in the healthcare sector. In short, this technology allows us to create a virtual representation of a physical object or system. The options have expanded during recent years to include large items such as buildings, factories, and even people.

This article takes a deep dive into the digital twins technology. You'll discover what a digital twin is, and how they are being used in different industries. And more importantly, you will learn more about the role of digital twins in the healthcare industry, as well as find out three future-thinking startups that are shaping this landscape.

Digital Twin Startups Revolutionizing Healthcare

Unlearn.AI

Unlearn.AI is advancing a platform to accelerate clinical trials for Alzheimer's Disease, Multiple Sclerosis, and other complex diseases. By leveraging historical datasets and disease-specific machine-learning models, Unlearn generates virtual placebo patients created from actual patient baseline data in clinical studies. This approach increases trial power and confidence, accelerates trial timelines, and enables patient-level insights which in turn reduces the time to develop new medicines.

Currently, Unlearn.AI is using machine learning for comprehensive forecasting of Alzheimer's Disease progression. Most approaches to machine learning from electronic health data can only predict a single endpoint. The ability to simultaneously simulate dozens of patient characteristics is a crucial step towards personalized medicine for Alzheimer's Disease.

Enter your email address to download paper.

Click the link to begin download.
Oops! Something went wrong while submitting the form.

Enter your email address to watch the webinar.

Click the link to watch webinar.
Oops! Something went wrong while submitting the form.
Webinars

Applying Machine Learning to Increase Clinical Trial Efficiency: A Regulatory Journey

Press

Unlearn Closes $50 Million Series B Funding to Advance the Use of Its Machine Learning-Powered TwinRCTs™ in Clinical Trials

Press

Unlearn Signs Multi-Year Collaboration with Merck KGaA, Darmstadt, Germany to Accelerate Immunology Trials using Twintelligent RCTs™

Collaborators will leverage AI-generated Digital Twins to enable smaller, more efficient pivotal clinical trials.
Led by Insight Partners, financing builds on the company’s momentum in working with leading biopharmaceutical companies to improve clinical trial efficiency.
Learn about the evolution of ideas that led to our TwinRCT™ solution for smaller, more efficient clinical trials and recent EMA draft qualification opinion.